Natriuretic peptides and chronic heart failure in arterial hypertension patients

Natriuretic peptides and chronic heart failure in arterial hypertension patients

The review is devoted to natriuretic peptides perspectives in left ventricular (LV) systolic and diastolic dysfunction assessment and LV hypertrophy diagnostics in arterial hypertension (AH) patients. The data describing possible antihypertensive therapy effects on brain natriuretic peptide level in...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yu. A. Vasuyk, A. B. Khadzegova, S. V. Ivanova, I. M. Amirbegishvili, N. I. Gerasimova, E. N. Yushchuk, O. V. Krikunova, V. G. Bitsuev
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2007-04-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	natriuretic peptides left ventricular dysfunction arterial hypertension
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1208
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The role of brain natriuretic peptide and NT- probrain natriuretic peptide in diagnostics of chronic heart failure and asymptomaticleft ventricular dysfunction in patients with type 2 diabetes mellitus
by: Irina Arkad'evna Bondar', et al.
Published: (2011-09-01)

Point-of-care N-terminal pro-brain natriuretic peptide testing in patients with heart failure: data from the DREAM study
by: F. I. Belyalov, et al.
Published: (2024-06-01)

Parallels of structural-functional parameters the myocardium, C-type natriuretic peptide and endothelin-1 plasma concentrations in women with uncomplicated essential hypertension
by: V. V. Petrovska, et al.
Published: (2014-12-01)

Blood concentrations of B-type natriuretic peptide and N-terminal prohormone B-type natriuretic peptide as markers of left ventricle diastolic function in patients with chronic renal failure
by: Petrović Milica, et al.
Published: (2017-01-01)

ON THE GENETIC REGULATION OF BRAIN NATRIURETIC PEPTIDE LEVEL IN PLASMA OF MEN WITH ESSENTIAL HYPERTENSION
by: I. P. Pashkovа, et al.
Published: (2017-03-01)

BRAIN NATRIURETIC PEPTIDE AS BIOCHEMICAL MARKER FOR STRUCTURAL AND FUNCTIONAL HEART DISORDERS IN ARTERIAL HYPERTENSION
by: S. V. Ivanova, et al.
Published: (2015-12-01)

Effect of six weeks low intensity interval training on expression of atrial and brain natriuretic peptide genes following myocardial infarction in rat
by: mehran ghahremani, et al.
Published: (2019-07-01)

Role of brain natriuretic peptide in the pathogenesis of resistant hypertension
by: K. Yu. Nikolaev, et al.
Published: (2023-02-01)

A two-centre study investigating the association between brain natriuretic peptides & outcomes in continuous flow left ventricular assist device recipients
by: Maria Lambadaris, et al.
Published: (2025-04-01)

Association of genetic polymorphisms of brain natriuretic peptide with cardiovascular diseases
by: A. Ya. Panarina, et al.
Published: (2024-11-01)

Assessment of glomerular and tubulointerstitial apparatus state depending on the level of the natriuretic peptide in hypertension patients
by: A. I. Chernyavina
Published: (2020-04-01)

INTEGRATION OF BIOMARKERS INTO THE PRACTICE OF TREATING PATIENTS WITH HEART FAILURE: THE ROLE OF DETERMINING THE BLOOD LEVEL OF NATRIURETIC PEPTIDES
by: S. R. Gilyarevskiy, et al.
Published: (2017-12-01)

B-type natriuretic peptide informativeness in myocardial revascularization with cardio-pulmonary bypass
by: I. A. Kozlov, et al.
Published: (2024-08-01)

Decoding Survival in Elderly Acute Myocardial Infarction: The Prognostic Interplay of B-Type Natriuretic Peptide, Ejection Fraction, and Renal Function – An Observational Study
by: Rajpal Prajapati, et al.
Published: (2025-04-01)

Brain natriuretic peptide, structural and functional cardiac remodeling in chronic heart failure with overweight and obesity
by: V. D. Syvolap, et al.
Published: (2014-06-01)

GENDER AND AGE DIFFERENCES OF BRAIN NATRIURETIC PEPTIDE CONCENTRATION IN PATIENTS WITH MYOCARDIAL INFARCTION
by: E. N. Usoltseva, et al.
Published: (2014-07-01)

Awareness, access, and adoption of natriuretic peptides for diagnosis of heart failure
by: Antoni Bayes‐Genis, et al.
Published: (2025-02-01)

NATRIURETIC PEPTIDE AND HIS PROGENITORS AS PREDICTORS OF PROGRESSIVE POSTOPERATIVE LEFT VENTRICLE REMODELING IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY
by: S. S. Gutor, et al.
Published: (2013-12-01)

Modification of the Association of B-Type Natriuretic Peptides With Mortality and Hospitalization Outcomes by Sex
by: David Bobrowski, MD, et al.
Published: (2025-08-01)

Brain natriuretic peptide: diagnostic and prognostic value in chronic heart failure (a literature review)
by: O. O. Sakovych, et al.
Published: (2024-05-01)

The Effect of Recombinant Human Brain Natriuretic Peptide Combined with Xinmailong on Heart Failure and Its Impact on Cardiac Function and Inflammatory Response
by: Ge Z, et al.
Published: (2025-04-01)

TISSUE DOPPLEROGRAPHY IN EARLY DIAGNOSIS OF FUNCTIONAL MYOCARDIAL DISORDERS IN ARTERIAL HYPERTENSION
by: Y. A. Vasyuk, et al.
Published: (2016-01-01)

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

Natriuretic peptides: new challenges — new solutions
by: O. M. Drapkina, et al.
Published: (2021-11-01)

Increased natriuretic peptides not associated with heart failure
by: A. M. Chaulin, et al.
Published: (2021-01-01)

N-terminal pro-brain natriuretic peptide in essential arterial hypertension patients: antihypertensive therapy effects
by: A. S. Galyavich, et al.
Published: (2006-10-01)

Role of natriuretic peptides in the assessment of aortic stenosis severity
by: Davičević Žaklina, et al.
Published: (2010-01-01)

Evaluation of left ventricular functions with two-dimensional speckle-tracking echocardiography (2D-STE) and N-terminal ProBNP in diabetic children
by: Ayşe Şimşek, et al.
Published: (2018-12-01)

Features of the Clinical Signs, Changes of the Natriuretic Propeptide (NT-proBNP), Left Ventricular Diastolic Function and Heart Rate Variability in the Patients with the Stable Angina Pectoris Combined with Thyroid Hypofunction
by: Shved M., et al.
Published: (2015-03-01)

High Serum Adrenomedullin and Mid-Regional Pro-Atrial Natriuretic Peptide Concentrations in Early Pregnancy Predict the Development of Gestational Hypertension
by: Aleksandra Jagodzinska, et al.
Published: (2024-11-01)

Effect of 24 sessions of high intensity interval training on serum levels of B-type Natriuretic Peptide (BNP) in patients with heart failure
by: M siufjahromi, et al.
Published: (2017-10-01)

Pro-C-Type Natriuretic Peptide in Women With Angina Pectoris and No Obstructive Coronary Artery Disease
by: Peter D. Mark, MD, PhD, et al.
Published: (2025-07-01)

Natriuretic peptides modulate monocyte-derived Langerhans cell differentiation and promote a migratory phenotype
by: Dorottya Horváth, et al.
Published: (2025-06-01)

Supramolecular complex sacubitril/valsartan - the first representative of a new class of drugs for the treatment of chronic heart failure
by: T. V. Ashcheulova, et al.
Published: (2019-12-01)

Correlation of N-terminal pro-B-type natriuretic peptide with clinical parameters in patients with hypertension
by: Pejović Janko, et al.
Published: (2013-01-01)

CLINICAL SIGNIFICANCE OF DETERMINING THE LEVEL OF THE BRAIN NATRIURETIC PEPTIDE FOR THE DIAGNOSIS OF HEART FAILURE OF COMORBID PATIENTS WITH CORONARY HEART DISEASE AND THYROTOXICOSIS
by: E. V. Pashchenko, et al.
Published: (2017-09-01)

Possibilities of Using Blood Natriuretic Peptide Levels as Biomarkers of Morbidity and Aging
by: Dzeranova, N.Y., et al.
Published: (2024-12-01)

Heart and pulmonary artery remodeling association with various levels of natriuretic peptides and renin-angiotensin-aldosterone system activation in patients with pulmonary hypertension of various etiology
by: Yu. A. Andreeva, et al.
Published: (2008-12-01)

Brain natriuretic peptide and all-cause mortality in patients treated with haemodialysis
by: Maria K Svensson, et al.
Published: (2025-06-01)

Risk factors and diagnostic value of urinary N-terminal pro-brain natriuretic peptide for verification of heart failure in human immunodeficiency virus-infected patients
by: O. G. Goryacheva, et al.
Published: (2022-03-01)